Le Lézard
Classified in: Science and technology, Business
Subject: LAW

CIRO Hearing Panel issues Reasons for Decision in the matter of Gravitas Securities and Blayne Creed


TORONTO, Nov. 30, 2023 /CNW/ - Following a settlement hearing held on October 3, 2023, in Toronto, Ontario, a hearing panel of the Investment Dealer Division of the Canadian Investment Regulatory Organization (CIRO) found that Gravitas Securities failed to have and maintain risk adjusted capital greater than zero and Blayne Creed, Ultimate Designated Person of Gravitas Securities, failed to promote compliance by Gravitas Securities with the rules by agreeing to participate in a bought deal financing, which resulted in Gravitas Securities' capital deficiency.

The hearing panel's reasons for decision, dated October 24, 2023, are available at:

Re Gravitas Securities and Blayne Creed 2023 CIRO 30

In its reasons for decision, the hearing panel confirmed the sanctions imposed on the Respondents.

In particular, Gravitas Securities agreed to:

a)      disgorge its portion of the commissions from the financing in the amount of $38,834.40.

Blayne Creed agreed to:

a)      disgorge his portion of the commissions from the financing in the amount of $38,834.40;

b)      a fine of $40,000; and

c)       a prohibition on his approval in the category of Ultimate Designated Person for a period of one year.

Mr. Creed also agreed to pay costs in the amount of $15,000.

The violations occurred while Blayne Creed was a Registered Representative, Ultimate Designated Person, Interim President and Chief Executive Officer of Gravitas Securities Inc. Gravitas Securities Inc. has been a Dealer Member since 2008. In June 2023, its membership with CIRO was suspended per Re Gravitas 2023 CIRO 02.

All information about disciplinary proceedings relating to current and former member firms and individual registrants is available in the Enforcement section of the IIROC website for investment dealer disciplinary proceedings and the MFDA website for mutual fund dealer disciplinary proceedings.

Background information regarding the qualifications and disciplinary history, if any, of advisors currently employed by CIRO-regulated firms (Investment Dealer Division) is available free of charge through the AdvisorReport service. Information on how to make investment dealer, advisor or marketplace-related complaints is available by calling 1-877-442-4322.

CIRO investigates possible misconduct by its member firms and individual registrants. It can bring disciplinary proceedings which may result in sanctions including fines, suspensions, permanent bars, expulsion from membership, or termination of rights and privileges for individuals and firms.

The Canadian Investment Regulatory Organization (CIRO) is the national self-regulatory organization that oversees all investment dealers, mutual fund dealers and trading activity on Canada's debt and equity marketplaces. CIRO is committed to the protection of investors, providing efficient and consistent regulation, and building Canadians' trust in financial regulation and the people managing their investments. For more information, visit www.ciro.ca.

SOURCE Canadian Investment Regulatory Organization (CIRO)


These press releases may also interest you

at 10:05
Intelligent power management company Eaton participated in The White House Office of the National Cyber Director's Convening on Cyber Workforce event on April 29 to underscore its commitment to cybersecurity training across industries. The company's...

at 10:01
The IoT technology market is projected to grow from USD 945.6 billion in 2024 to USD 1,377.8 billion by 2029, registering a CAGR of 7.8% during the forecast period according to a new report by MarketsandMarketstm. The market growth is attributed to...

at 10:00
Blanc Labs, a leader in Lending Technology, AI, and Business Process Improvement, is excited to announce a strategic partnership with TCG Process, leveraging their DocProStar platform to transform lending operations for mid-tier banks, credit unions,...

at 10:00
RevOpsis Therapeutics, a next-generation biopharmaceutical company spearheading innovation in ophthalmic therapies, announced today the appointment of Dr. Emmett Cunningham to its Strategic Advisory Board (SAB) and as a private investor. Dr....

at 10:00
MMA Global, a not-for-profit organization, dedicated to elevating marketing practices, is proud to announce that entries for the highly anticipated 2024 SMARTIEStm Awards are officially open. This prestigious program transcends a mere competition; it...

at 10:00
Panasonic has recently introduced the CR-LAZ to its range of Long-Life Cylindrical Lithium batteries. The CR-LAZ battery technology provides reliable, consistent performance and is ideal for applications that require long-term use of up to 15 years....



News published on and distributed by: